Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	29094-61-9
Formula :	C₂₁H₂₇N₅O₄S
M.W :	445.54
SMILES Code :	O=C(NS(=O)(C1=CC=C(CCNC(C2=NC=C(C)N=C2)=O)C=C1)=O)NC3CCCCC3
Synonyms :	K 4024; CP 28720; Ozidia
MDL No. :	MFCD00072159
InChI Key :	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
Pubchem ID :	3478

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H320-H335
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338

DU145 cells	50–200 µM	48 hours or 72 hours	Glipizide showed no significant effect on DU145 cell proliferation	Sci Rep. 2016 Jun 13;6:27819.
PC-3 cells	50–200 µM	48 hours or 72 hours	Glipizide showed no significant effect on PC-3 cell proliferation	Sci Rep. 2016 Jun 13;6:27819.

Dogs	Healthy dogs	Oral	10 mg/day	Once daily for 10 to 20 days	To examine the effects of chronic glipizide treatment on insulin-mediated glucose disposal. Results showed that glipizide treatment significantly increased insulin-mediated overall glucose disposal (Rd) but had no significant effect on insulin suppression of hepatic glucose production (Ra).	J Clin Invest. 1981 Apr;67(4):1016-23
Sprague-Dawley rats and Swiss Albino Mice	STZ-induced diabetic mice model	Oral	2 mg/kg	Single dose (rats) and 28 days continuous administration (mice)	To evaluate the long-term glucose-lowering effect of glipizide microspheres in diabetic models. Results showed that compared to immediate-release formulations, the microspheres provided a more sustained reduction in blood glucose and showed persistent effects even after cessation of treatment.	Saudi Pharm J. 2011 Jul;19(3):143-52
Beagle dogs	Healthy male Beagle dogs	Oral	5 mg	Single dose, with a washout period of one week	Evaluate the impact of particle size on in vivo absorption. Results showed that formulations with API particle sizes in the range of 2–5 μm exhibited similar oral absorption compared to the reference product.	Asian J Pharm Sci. 2019 Mar;14(2):165-173
TRAMP mice ([C57BL/6 × FVB]F1 background)	Spontaneous prostate adenocarcinoma model	Intraperitoneal injection	5 mg/kg	Every three days for 8 weeks	Glipizide significantly suppresses prostate cancer growth and metastasis by inhibiting tumor-induced angiogenesis rather than tumor cell proliferation	Sci Rep. 2016 Jun 13;6:27819.
Wistar rats	Normal and diabetic rat models	Oral	5 mg/kg	7 or 28 days	To evaluate the effects of APE and AND on the pharmacokinetic parameters of glipizide. APE significantly improved the Cmax and AUC0–t/AUC0–∞ values of GLZ in normal and diabetic rats (p < 0.05). AND significantly reduced the bioavailability of GLZ in diabetic rats, as indicated by decreased values of T1/2, Cmax, and AUC0–t/AUC0–∞ (p < 0.05).	Molecules. 2022 Oct 14;27(20):6901

{[proInfo.proName]}

CAS No.: 29094-61-9

{[proInfo.proName]}

CAS No.: 29094-61-9

Alternative Products

Product Details of Glipizide

Safety of Glipizide

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02456428	-		Completed	-	Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02475499	-		Completed	-	Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT03492580	-		Completed	-	United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT02476760	-		Completed	-	Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT01068860	Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less <<	Phase 2	Completed	-	-
NCT00691314	Stroke Transi... More >>ent Ischemic Attack Atherosclerosis Stenosis Stents Less <<	Not Applicable	Completed	-	China, Beijing ... More >> Beijing Tiantan Hospital Beijing, Beijing, China, 100050 Xuanwu Hospital Capital Medical University Beijing, Beijing, China, 100053 Peking Union Medical College Hospital Beijing, Beijing, China, 100730 China, Chongqing Southwest Hospital Chongqing, Chongqing, China, 400038 Daping Hospital Chongqing, Chongqing, China, 400042 China, Jiangsu Nanjing General Hospital of Nanjing Military Command Nanjing, Jiangsu, China, 210002 China, Jilin Jilin University Changchun, Jilin, China, 130021 China, Shanghai Huashan Hospital Fudan University Shanghai, Shanghai, China, 200040 China, Sichuan West China Center of Medical Sciences Chengdu, Sichuan, China, 610041 China, Tianjin The General Hospital Under Tianjin Medical Sciences University Tianjin, Tianjin, China, 300052 Less <<
NCT01068860	-		Completed	-	-
NCT00547274	Diabetes Mellitus, Type II ... More >> Dyslipidemia Less <<	Phase 3	Terminated	-	-
NCT00032474	Type 2 Diabetes Mellitus	Phase 1 Phase 2	Completed	-	United States, Texas ... More >> University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 Less <<
NCT00885352	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT00350779	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT00885352	-		Completed	-	-
NCT00350779	-		Completed	-	-
NCT00575588	Type 2 Diabetes	Phase 3	Completed	-	-
NCT00664846	Stroke	Not Applicable	Completed	-	-
NCT00575588	-		Completed	-	-
NCT00543010	Diabetes Mellitus, Type 2	Phase 3	Terminated	-	-
NCT00095056	-		Completed	-	-
NCT00086515	-		Completed	-	-
NCT00347100	Diabetes Mellitus, Type 2	Phase 4	Completed	-	China ... More >> Sanofi-Aventis Beijing, China Less <<
NCT01020123	Type II Diabetes Mellitus	Phase 2	Completed	-	-
NCT00513630	Type 2 Diabetes ... More >> Coronary Artery Disease Less <<	Phase 4	Completed	-	China ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, China, 200025 Less <<
NCT00086515	Diabetes Mellitus, Type II	Phase 3	Completed	-	-
NCT01020123	-		Completed	-	-
NCT01698775	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT01698775	-		Completed	-	-
NCT00116831	Atherosclerosis	Phase 3	Completed	-	-
NCT01758471	Type 2 Diabetes	Phase 4	Unknown	June 2014	China, Shanghai ... More >> Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, M.D. 86-021-64370045 ext 665344 Less <<
NCT02608177	Chronic Kidney Diseases ... More >> Type 2 Diabetes Less <<	Not Applicable	Completed	-	United States, Washington ... More >> University of Washington Seattle, Washington, United States Less <<
NCT01267448	Diabetes Mellitus Type 2 ... More >> Severe Hyperglycemia - Blood Glucose Level >300mg/dl. Less <<	Phase 4	Unknown	December 2012	United States, Illinois ... More >> John Stroger Hospital of Cook County Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D. 312-864-0543 Ambika_Babu@rush.edu Contact: Leon Fogelfeld, M.D. 312-864-0539 lfogelfe@cchil.org Principal Investigator: Ambika Babu, M.D. John Stroger Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D. 312-864-0543 aamblee@hotmail.com Contact: Leon Fogelfeld, M.D. 312-864-0539 lfogelfe@cchil.org Principal Investigator: Ambika Babu, M.D. Less <<
NCT00806013	-		Completed	-	China, Liaoning ... More >> The second hospital to Liaoning University of TCM Shenyang, Liaoning, China, 201203 Less <<
NCT00095056	Diabetes Mellitus, Type 2 ... More >> Chronic Renal Insufficiency Less <<	Phase 3	Completed	-	-
NCT00116831	-		Completed	-	-
NCT02608177	-		Completed	-	-
NCT00094770	-		Completed	-	-
NCT01951651	Type 2 Diabetes Mellitus	Phase 4	Completed	-	United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01951651	-		Completed	-	-
NCT00094770	Diabetes Mellitus, Type 2	Phase 3	Completed	-	-
NCT00660907	Type 2 Diabetes	Phase 3	Completed	-	-
NCT00550329	-		Completed	-	Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00649454	Healthy	Phase 1	Completed	-	United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00947024	Type 2 Diabetes	Phase 1	Completed	-	-
NCT00660907	-		Completed	-	-
NCT00648505	Healthy	Phase 1	Completed	-	United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00856284	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT00834587	Healthy	Phase 1	Completed	-	United States, Minnesota ... More >> PRACS Institute Ltd. East Grand Forks, Minnesota, United States, 56721 United States, North Dakota PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00834587	-		Completed	-	-
NCT00856284	-		Completed	-	-
NCT00509262	Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency, Chronic Less <<	Phase 3	Completed	-	-
NCT00835497	-		Completed	-	-
NCT00509262	-		Completed	-	-
NCT00707993	Diabetes Mellitus	Phase 3	Completed	-	-
NCT00732524	Type 2 Diabetes	Phase 4	Completed	-	United States, Illinois ... More >> John H Stroger Hospital Of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT00707993	-		Completed	-	-
NCT01082796	Genotype\|Pharmacokinetic		COMPLETED	2025-01-10	Departmant of Clinical Pharmac... More >>ology, the First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, 730000, China Less <<
NCT00509236	-		Completed	-	-
NCT01762046	Diabetes Mellitus, Type 2	Phase 1	Active, not recruiting	October 2017	United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02116 Joslin Diabetes Center Boston, Massachusetts, United States, 02116 Less <<
NCT00835497	Healthy	Phase 1	Completed	-	United States, Minnesota ... More >> PRACS Institute Ltd. East Grand Forks, Minnesota, United States, 56721 United States, North Dakota PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00509236	Diabetes Mellitus, Type 2 ... More >> End-Stage Kidney Disease Less <<	Phase 3	Completed	-	-
NCT00946504	Type 2 Diabetes	Phase 1	Completed	-	-
NCT06168812	Pancreatic Cancer\|Pancreatic C... More >>arcinoma\|Pancreatic Ductal Adenocarcinoma\|Pancreatic Cancer Metastatic\|Metastatic Pancreatic Cancer\|Metastatic Pancreatic Ductal Adenocarcinoma Less <<	PHASE2	RECRUITING	2025-12-05	Memorial Sloan Kettering at Ba... More >>sking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States\|Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, 07748, United States\|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States\|Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack, New York, 11725, United States\|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States\|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States\|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, 11553, United States Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.24mL 0.45mL 0.22mL	11.22mL 2.24mL 1.12mL	22.44mL 4.49mL 2.24mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed